SciELO - Scientific Electronic Library Online

 
vol.86 issue4Investigation of latent tuberculosis infection in patients with psoriasis who are candidate for receiving immunobiological drugsUltraviolet radiation protection: current available resources in photoprotection author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Anais Brasileiros de Dermatologia

Print version ISSN 0365-0596

An. Bras. Dermatol. vol.86 no.4 Rio de Janeiro July/Aug. 2011

http://dx.doi.org/10.1590/S0365-05962011000400015 

REVIEW

 

Superficial mycosis and the immune response elements*

 

 

Paulo Ricardo CriadoI; Cristiane Beatriz de OliveiraII; Kátia Cristina DantasIII; Filomena Amaro TakigutiIV; Luciana Vasconcellos BeniniV; Cidia VasconcellosVI

IPhD Professor - Physician of the Department of Dermatology, Clinics Hospital, Faculty of Medicine, University of São Paulo and Professor of the graduate program of the Department of Dermatology, Faculty of Medicine, University of São Paulo - São Paulo (SP), Brazil
IIMSc student of the Department of Dermatology, Faculty of Medicine, University of São Paulo - Dermatologist - São Paulo (SP), Brazil
IIIMSc in Medical Physiology - - Pharmacist of the Medical Mycology Laboratory of the Tropical Medicine Institute of São Paulo, University of São Paulo - São Paulo (SP), Brazil
VIUndergraduate student - Undergraduate student of Medicine, Faculty of Medicine, University of São Paulo - São Paulo (SP), Brazil
VUndergraduate - Undergraduate student of Pharmacy and Biochemistry, Oswaldo Cruz Faculties of São Paulo - São Paulo (SP), Brazil
VIPhD Professor - Professor of the graduate program in Health Sciences, IAMSPE; Professor, São Paulo-City University (UNICID); Professor of the graduate program of the Department of Dermatology, Faculty of Medicine, University of São Paulo - São Paulo (SP), Brazil

Mailing address

 

 


ABSTRACT

Superficial mycoses are prevalent worldwide. They are often caused by dermatophytes and restricted to the stratum corneum. The host's immune response against infections caused by dermatophytes basically depends on the host's defense against metabolites of the fungi, virulence of the infecting strain or species and anatomical site of the infection. We will review some of the factors of the host's immune defense that influence the efficacy of the immune response. We will particularly review the role of pattern recognition receptors (PRRs), such as toll-like receptors or lectin receptors (DCSIGN and Dectin 2), which participate in the innate immune response, bringing specificity to the immune response and setting its pattern. The predominance of a cellular or humoral immune response determines the clinical manifestations and the prognosis of the infection, leading to healing or chronicity.

Keywords: Allergy and immunology; Fungi; Inflammation mediators; Integumentary system


 

 

INTRODUCTION

Superficial mycoses are common in tropical countries like Brazil. They are usually caused by dermatophytes and restricted to the stratum corneum.1 The host immune response against infections caused by dermatophytes depends on factors such as the host defenses against metabolites of the fungus, the virulence of the infecting strain or species, the anatomical site of infection and local environmental factors.1

The most prevalent dermatophytes are mainly those of the genera - Trichophyton, Microsporum and Epidermophyton,2 classified as anthropophilic, zoophilic and geophilic according to their primary habitat.3,4 The most common infection in the Americas and in parts of Europe is caused by anthropophilic dermatophytes.5

The Trichophyton rubrum, an anthropophilic dermatophyte, can cause non-inflammatory chronic infections of the skin, which could facilitate its transmission.4 Transfer of infectious soil organisms to other animals or humans occurs through arthrospores, skin scales or hair, with direct contact not being necessary.1 Invasion of the skin follows adhesion of fungal cells to keratinocytes.6

2. Factors Predisposing to Skin Infections Caused by Dermatophytes

2.1 Factors related to the host

Susceptibility to dermatophytosis is variable.7 Individual susceptibility factors are still unclear and may be related to variations in the composition of sebum fatty acids, skin surface carbon dioxide tension, presence of moisture or presence of inhibitors for the growth of dermatophytes in sweat or serum, such as transferrin.8

It was experimentally observed that the main efferent arm of immune resistance to fungal infection is T lymphocytes, which are not influenced by administration of specific antibodies. Apparently, the kinetics of the immune response in humans would be similar: during infection, there is the development of both delayed hypersensitivity skin reaction to trichophytin and blastogenic response of T lymphocytes with progression to healing,9 which relates chronicity to incomplete cellular immune responses. 10

Participation of each element of the immune response has been explored and gradually elucidated over time: Langerhans cells (LC) act as antigen presenting cells; mononuclear phagocytes, especially polymorphonuclear neutrophils, lyse dermatophytes both intra and extracellularly via the oxidative pathway; 7 and dermatophyte antigens have shown to be chemotactic to human leukocytes, activating the alternative pathway of the complement.11

However, with the exception of clinical cases of inflammatory tinea, neutrophils are not usually seen as part of the inflammatory infiltrate observed in histological sections under the microscope. This indicates that other mechanisms of fungal clearance must be involved in this process.11

The mechanism(s) through which lymphocytes affect recovery from the disease are less known. It is believed that the immune system amplifies an endogenous epidermal response to infection, since a high rate of epithelial replacement with peak at the maximal immune response is observed. It is possible that elimination of dermatophytes is also accomplished by this shedding of the stratum corneum. 12

2.2 Factors related to dermatophytes

Factors related to the fungus also contribute to development of infection. Different dermatophyte species vary in their ability to stimulate an immune response: organisms such as Trichophyton rubrum cause chronic or relapsing infections, whereas other fungi induce resistance to reinfection.3,6 Some dermatophytes produce glycopeptides that are able to reversibly inhibit blastogenesis of T lymphocytes in vitro, thus modulating host immunity.3

It is important to emphasize that dermatophytes cause infection regardless of the patient's immune status.13 On rare occasions, individuals that are immunocompromised or not develop infections caused by dermatophytes with invasion of subcutaneous tissue. However, the clinical aspect varies. It is less inflammatory in individuals with impaired function of T lymphocytes.14

Dermatophyte infections induce specific humoral and cellular immune response,15-17 with protective response against dermatophytes being mediated primarily by delayed type hypersensitivity reaction, which is characterized by the action of macrophages as effector cells with increased activity of key cytokines of the Th1 pole (Type 1 T helper lymphocytes), such as IL-12 (interleukin-) and INF-γ (interferon gamma). 15

Thus, the fungus/host interaction, which includes fungus species, host species, immmune response capacity and response modulation by the parasite, will exert influence on the degree of inflammatory reaction, which will define the clinical presentation and duration of the lesion. 15

Chronic or relapsing infections with T. rubrum in immunocompetent individuals are related to the prevalence of immediate hypersensitivity mediated by IgE (immunoglobulin E) to the fungus, as well as high serum levels of IgE and IgG4 (immunoglobulin G4). 15

3. Cellular, innate and humoral immunity in dermatophytosis

There is increasing evidence that both anti-fungal protective and non-protective antibodies (inhibitors/blockers) coexist18 and that host protection could be conferred by induction of appropriate humoral response,19 since the production of antibodies by the host is induced by antigens secreted by dermatophytes during the early phase of invasion of the stratum corneum, such as keratinolytic proteases. 6. 20-22

The role of innate immunity in dermatophytoses remains uncertain. It is known that keratinocytes are the first cellular elements with which dermatophytes come into contact during infection15 and that they modulate the host immune response.23 Upon exposure to dermatophytes or their antigens, these keratinocytes produce a wide range of cytokines, which include IL-8 (potent neutrophil chemotactic factor) and the pro-inflammatory cytokine TNF (tumor necrosis factor alpha),24 which, together, can destroy dermatophytes. The various species of dermatophytes differ in their ability to induce secretion of proinflammatory cytokines in keratinocytes. Zoophilic species, for instance, are more effective in causing a greater degree of inflammation in the host's skin. 25

Human keratinocytes also secrete antimicrobial peptides such as cathelicidins and defensins with potential antifungal activity.15 Several authors have shown that human ,-defensin and cathelicidin LL-37 are fungistatic and fungicidal in vitro against T. rubrum and that their expression is increased in vivo in tinea corporis caused by this fungus.26,27

As for epidermal dendritic cells (DC), especially LC, they are essential to initiate and modulate adaptive responses of the immune system against dermatophytes.15 They are usually equipped with receptors for pathogen-associated molecular patterns called pattern recognition receptors (PRRs). These PRRs include Tolllike receptors (TLRs), which have a central role in the activation of DC, and lectin and lectin-like receptors, specialized in recognizing pathogen structures associated with carbohydrates. An important example is DC-SIGN (CD209) [dendritic cell-specific intercellular adhesion molecule-3 (ICAM-3)-grabbing non-integrin], a type II transmembrane protein belonging to the C-type lectin family of the PRRs.28,29

The study of the role of PRRs in immune response to fungi could explain the chronicity of some infections. Several molecules have been described, including Dectin-2, a C-type lectin-like receptor expressed in most differentiated DC, such as LC, which is able to recognize and bind to M. canis and T. rubrum hyphae, determining the secretion of proinflammatory cytokines such as TNFα.28 In contrast to this immunostimulatory effect, phagocytosis of T. rubrum conidia by macrophages induces secretion of IL-10, a cytokine with anti-inflammatory properties, while other factors related to protective immunity [such as human leukocyte antigen class II (MHC-II), CD54 and CD80 lymphocytes (costimulatory molecules), nitric oxide and IL-12] are suppressed. 30

In addition to keratinocytes and DC, neutrophils are important cellular elements in innate immunity to dermatophytes, accumulating early - soon after the adherence of conidia to corneocytes - during germination. Neutrophils are believed to be, together with macrophages, the final effector cells in elimination of dermatophytosis, via Th1-dependent inflammatory response (Figure 1).15

Several studies suggest that the immunosuppressive properties of the mannans are responsible for the chronicity of dermatophytosis by T. rubrum in humans.15 One of them emphasizes that phagocytosis of T. rubrum conidia by macrophages is inhibited by the mannans of the fungal wall and by their exo-anti gen.25

Mannans derived from dermatophytes can inhibit DC-SIGN-dependent cell adesion to ICAM-3 of wild-type T cells, which raises the hypothesis that dermatophyte mannans could also avoid initial interactions between DC and wild-type T cells, thus blocking antigen presentation and activation of T cells, favoring the development of invasive or disseminated infections caused by dermatophytes.31

The expression of DC-SIGN is IL-4 dependent and is detected in both DC and subtypes of macrophages in vivo.32 DC-SIGN recognizes carbohydrates with mannose and Ca2+-dependent oligosaccharides on the surface of various pathogens such as Candida albicans, Aspergillus fumigatus and Chrysosporium tro

picum.32 Although the function of this receptor in immune response to fungi has not yet been extensively studied, it is believed that DC-SIGN mediates fungal capture, internalizing antigens through endocytosis,32 as well as intercellular adhesion, recognizing endogenous molecules such as ICAM-2 on the surface of endothelial cells and ICAM-3 on the surface of wildtype T-cells.32

In fact, some characteristics of the immunomodulation practiced by dermatophytes seem to depend not only on factors produced by them in the course of infection but also on how they are detected by the host.15 Alike Zymosan, which is derived from the yeast cell wall and considered an inducer of proinflammatory cytokines, which was recently identified as an inducer of DC regulating immunological tolerance via TLR2 and Dectin-1 and a mediator of IL-10 release. 33

Virulence factors of dermatophytes contribute to modulation of the host immune response and can be expressed throughout the whole infectious process.34,35 Among these factors are cell wall glycoproteins, endoproteases and exoproteases (the latter isolated from T. rubrum and M. canis).15

4. Toll-like receptors

TLRs have been observed in several skin cells, including keratinocytes and LC residing in the epidermis and other cells of the immune system (resident or non-resident in the dermis), such as macrophages, T and B cells, mast cells, endothelial cells in the microvasculature and stromal cells (fibroblasts and adipocytes).36 Since the epidermis is the primary site of dermatophyte infection, we focused on the study of TLR expression by keratinocytes and LC.

TLRs comprise a family of cell surface receptors and constitute key elements in innate or natural immune response, allowing control of the infection until the body orchestrates an antigen-specific immune response (acquired immunity).37 Although TLRs belong to the innate immune system, they present specificity of response and participate in controlling the activation of the acquired immune response.37

Currently, at least 13 different TLR(s) are known, 38 which recognize a wide variety of exogenous and endogenous antigens. The nature of the offending antigen and the TLR to which it binds will determine a specific repertoire of cytokines that is produced by antigen-presenting cells and polarize the acquired immune responses into Th1 or Th2 patterns (type 2 T-helper lymphocytes). 37

Human keratinocytes express TLRs from 1 to 10.39 Several studies have proved that these receptors are functional and participate in immune responses.38,39 In vitro In vitro studies found that the supernatant from keratinocytes stimulated via TLR3 may stimulate immature DC derived from monocytes toward cell differentiation and, consequently, production of TNFα and type I IFNγ (type I interferon gamma), developing Th1 cell responses from wild-type T cells.40 This indicates that keratinocytes can direct Th1-type adaptive immune responses.

Activation of different TLRs results in several patterns of immune response.41 Activation of TLR 3, 4, 5 and 9 in keratinocytes results in production of TNF , IL-8, chemokine CCL2 of monocytes and basophils and macrophage inflammatory protein-3 (CCL20). However, activation of TLR3 and 5 results in increased production of CCL27, promoting the recruitment of memory T cells specifically to the skin. Selective activation of TLR3 and 9 determines the production of CXCL9 and CXCL10, which are important for activation of memory T cells and induction of production of type-I IFN (IFN / ). These data demonstrate, in human keratinocytes, that functional TLRs may be important in the induction of different defense responses against various pathogens invading the skin.38

There are several studies on the expression and function of TLRs in human LC. 38.3 9 Comparative studies showed that LC-type DC express the messenger RNA (mRNA) of TLRs 1 to 10 in a way similar to monocyte-derived DC.42 However, LC-type DC are more responsive to TLR2 ligands (peptidoglycan) and TLR7/8 ligands (R-848 - resiquimod), determining the production of the cytokines IL-8, IL-12 and TNF and the chemokines CCL3 and CCL4. 42 It was also observed that stimulation of LC via TLR3 increased the production of INFγ, suggesting that LC could initiate a direct antiviral activity through stimulation of TLR3. Thus, it is believed that human LC express functional TLRs, which are more active to stimulation with TLR2, 3,7 and 8 ligands.38

In vitro studies with other fungi or yeast, such as C. albicans, have shown that TLR2 recognizes the glycopeptide phospholipmannan on the surface of the cell wall of the micro-organism and TLR4 recognizes the polysaccharide mannan, also on the fungal cell 43,44 That is, the expression of TLR2 and TLR4 in keratinocytes is important for the host defense against C. albicans. 45

Studies conducted in Paracoccidiodies brasiliensis, A. fumigatus and Cryptococcus neoformans suggest the involvement of TLRs in the recognition of these pathogens.44,46-49 In paracoccidioidomycosis, possible regulation of DC in susceptible mice was observed, promoting IL-10 production and contributing to the increased susceptibility mediated by the expression of TLR2.50

A possible mechanism of susceptibility was considered after an experimental comparison of the expression of DC in mice susceptible and in mice resistant to P. brasiliensis. There is reduced production o IL-10, IL-12 and TNF-α in mice resistant to fungal infection, whereas there would be increased production of TNF-α, IL-12, CD80 and CD54 in susceptible mice, as well as increased phagocytosis. Activation of TLR2 would be responsible for the production of IL10 and its increased production would contribute to increase susceptibility to infection. 50

There are still no published studies regarding the expression of TLRs in infections caused by dermatophytes in vivo.

It is suggested that T. rubrum has the ability to suppress the expression of TLR receptors in keratinocytes and LC necessary for stimulation of Th1-type cell response. Consequently, there would be marked expression of DC-SIGN in macrophages of the epidermis and dermis, which occurs in Th2-type responses, which are inadequate to fight fungal infection. This would allow a chronic and extensive infection caused by this dermatophyte to set in.

5. Final Thoughts

Although a reasonable number of in vitro or experimental studies is found in the literature, little is known about the immune response in vivo or the expression and role of TLRs, DC-SIGN, Dectin-2 and other molecules in skin infection caused by dermatophytes.

So far, what is more accepted is that superficial mycosis, with more or less clinical expression of inflammation, as well as its prognosis towards healing or chronicity, depends on cellular or humoral predominance in innate or acquired immune response.

Despite the fact that more and more is known and recognized about the immunological role of the skin, the histopathological and ultrastructural patterns of inflammatory response, in innate or acquired immunity of the skin, have not yet been accurately evaluated so that it is possible to define the role and involvement of immunocompetent cells resident in human epidermis when faced with the need to overcome superficial mycosis.

 

REFERENCES

1. Weitzman I, Summerbell RC. The Dermatophytosis. Clin Microbiol Rev. 1995;8:240-59.         [ Links ]

2. Havlickova B, Czaika VA, Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses. 2008;51:2-15.         [ Links ]

3. MacGregor JM, Hamilton A, Hay RJ. Possible mechanisms of immune modulation in chronic dermatophytosis - an in vitro study. Br J Dermatol. 1992;127:233-8.         [ Links ]

4. Rippon JW. Epidemiology and emerging patterns of dermatophyte species. In: Current topics in medical mycology. New York: I Springer-Verlag; 1985. p.288-34.         [ Links ]

5. Seebacher C, Bouchara JP, Mignon B. Updates on the epidemiology of dermatophyte infections. Mycopathologia. 2008;166:335-52.         [ Links ]

6. Vermout S, Tabart J, Baldo A, Mathy A, Losson B, Mignon B. Pathogenesis of dermatophytosis. Mycopathologia. 2008;166:267-75.         [ Links ]

7. Calderon RA. Immunoregulation in dermatophytosis. Crit Rev Microbiol. 1989;16:339-68.         [ Links ]

8. King RD, Khan HA, Foye JC, Greenberg JH, Jones HE. Transferrin, iron, and dermatophytes. I. Serum dermatophyte inhibitory component definitively identified as unsaturated transferrin. J Lab Clin Med. 1975;86:204-12.         [ Links ]

9. Jones HE, Reinhardt JH, Rinaldi MG. Acquired immunity to dermatophytosis. Arch Dermatol. 1974;109:840-8.         [ Links ]

10. Hay RJ, Reid S, Talwet E, Macnamara K. Immune responses of patients with tinea imbricata. Brit J Dermatol. 1983;108:581-9.         [ Links ]

11. Wagner DK, Sohnle PG. Cutaneous defenses against dermatophytes and yeasts. Clin Microb Rev. 1995;8:317-35.         [ Links ]

12. Cairas JÁ, Walls AF. Mast cell tryptase is a mitogen for epithelial cell. Stimulation of IL production and intracellular adhesion molecule-1 expression. J Immunol. 1996;156:275-83.         [ Links ]

13. Hay RJ. Dermatophytosis and other superficial mycosis. In: Principles and practice of infectious diseases. 4th ed. New York: Churchill-Livingstone; 1995. p. 2375-86.         [ Links ]

14. Allen DE, Snyderman R, Meadows L, Pinnell SR. Generalized Microsporum audouinii infection and depressed cellular immunity associated with a missing plasma factor required for lymphocyte blastogenesis. Am J Med. 1977;63:991-1000.         [ Links ]

15. Mignon B, Tabart J, Baldo A, Mathy A, Losson B, Vermout S. Immunization and dermatophytes. Curr Opin Infect Dis. 2008;21:134-40.         [ Links ]

16. Woodfolk JA, Platts-Mills TA. The immune response to dermatophytes. Res Immunol. 1998;149:436-45.         [ Links ]

17. Woodfolk JA. Allergy and dermatophytes. Clin Microbiol Rev. 2005;18:30-43.         [ Links ]

18. Martinez LR, Casadevall A. Specific antibody can prevent fungal biofilm formation and this effect correlates with protective efficacy. Infect Immun. 2005;73:6350-62.         [ Links ]

19. Cassone A. Fungal vaccines and vaccination: problems and perspectives. In: Brown GD, Netea MG, editors. Immunology of fungal infections. Heidelberg: Springer; 2007. p.465-85.         [ Links ]

20. Léchenne B, Reichard U, Zaugg C, Fratti M, Kunert J, Boulat O, et al. Sulphite efflux pumps in Aspergillus fumigatus and dermatophytes. Microbiology. 2007;153(Pt 3):905-13.         [ Links ]

21. Brouta F, Descamps F, Vermout S, Monod M, Losson B, Mignon B. Humoral and cellular immune response to a Microsporum canis recombinant keratinolytic metalloprotease (r-MEP3) in experimentally infected guinea pigs. Med Mycol. 2003;41:495-501.         [ Links ]

22. Mignon BR, Coignoul F, Leclipteux T, Focant C, Losson BJ. Histopathological pattern and humoral immune response to a crude exo-antigen and purified keratinase of Microsporum canis in symptomatic and asymptomatic infected cats. Med Mycol. 1999;37:1-9.         [ Links ]

23. Sugita K, Kabashima K, Atarashi K, Shimauchi T, Kobayashi M, Tokura Y. Innate immunity mediated by epidermal keratinocytes promotes acquired immunity involving Langerhans cells and T cells in the skin. Clin Exp Immunol. 2007;147:176-83.         [ Links ]

24. Nakamura Y, Kano R, Hasegawa A, Watanabe S. Interleukin-8 and tumor necrosis factor alpha production in human epidermal keratinocytes induced by Trichophyton mentagrophytes. Clin Diagn Lab Immunol. 2002;9:935-7.         [ Links ]

25. Tani K, Adachi M, Nakamura Y, Kano R, Makimura K, Hasegawa A, et al. The effect of dermatophytes on cytokine production by human keratinocytes. Arch Dermatol Res. 2007;299:381-7.         [ Links ]

26. Jensen JM, Pfeiffer S, Akaki T, Schröder JM, Kleine M, Neumann C, et al. Barrier function, epidermal differentiation, and human beta-defensin 2 expression in tinea corporis. J Invest Dermatol. 2007;127:1720-7.         [ Links ]

27. López-García B, Lee PH, Gallo RL. Expression and potential function of cathelicidin antimicrobial peptides in dermatophytosis and tinea versicolor. J Antimicrob Chemother. 2006;57:877-82.         [ Links ]

28. Sato K, Yang XL, Yudate T, Chung JS, Wu J, Luby-Phelps K, et al. Dectin-2 is a pattern recognition receptor for fungi that couples with the Fc receptor gamma chain to induce innate immune responses. J Biol Chem. 2006;281:38854-66.         [ Links ]

29. Saijo S, Ikeda S, Yamabe K, Kakuta S, Ishigame H, Akitsu A, et al. Dectin-2 recognition of ·-mannans and induction of Th17 cell differentiation is essencial for host defense against Candida albicans. Immunity. 2010;32:681-91.         [ Links ]

30. Campos MR, Russo M, Gomes E, Almeida SR. Stimulation, inhibition and death of macrophages infected with Trichophyton rubrum. Microbes Infect. 2006;8:372-9.         [ Links ]

31. Willment JA, Brown GD. C-type lectin receptors in antifungal immunity. Trends Microbiol. 2008;16:27-32.         [ Links ]

32. Serrano-Gómez D, Leal JA, Corbí AL. DC-SIGN mediates the binding of Aspergillus fumigatus and keratinophylic fungi by human dendritic cells. Immunobiology. 2005;210:175-83.         [ Links ]

33. Dillon S, Agrawal S, Banerjee K, Letterio J, Denning TL, Oswald-Richter K, et al. Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigenpresenting cells and immunological tolerance. J Clin Invest. 2006;116:916-28.         [ Links ]

34. Hay RJ, Calderon RA, Mackenzie CD. Experimental dermatophytosis in mice: correlation between light and electron microscopic changes in primary, secondary and chronic infections. Br J Exp Pathol. 1988;69:703-16.         [ Links ]

35. Acorci-Valério MJ, Bordon-Graciani AP, Dias-Melicio LA, Golim MA, Nakaira-Takahagi E, Soares AMVC. Role of TLR2 and TLR4 in human neutrophil functions against Paracoccidioides brasiliensis. Scandinavian Journal of Immunology. 2010;71:99-108.         [ Links ]

36. Miller LS, Modlin RL. Toll-like receptors in the skin. Semin Immunopathol. 2007;29:15-26.         [ Links ]

37. Kang SS, Kauls LS, Gaspari AA. Toll-like receptors: applications to dermatologic disease. J Am Acad Dermatol. 2006;54:951-83.         [ Links ]

38. Wei T, Gong J, Rossle SC, Jamitzky F, Heckl WM, Stark RW. A leucine-rich repeat assembly approach for homology modeling of the human TLR5-10 and mouse TLR 11-13 ectodomains. J Mol Model. 2010.         [ Links ]

39. Liu SJ, Zhang CP, Zhou WQ, Chen M, Lin L. Expression of toll-like receptors in human epidermal keratinocytes. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2008;30:296-300.         [ Links ]

40. Lebre MC, Antons JC, Kalinski P, Schuitemaker JH, van Capel TM, Kapsenberg ML Et AL. Double-stranded RNA-exposed human keratinocytes promote Th1 responses by inducing a Type-1 polarized phenotype in dendritic cells: role of keratinocyte-derived tumor necrosis factor alpha, type I interferons, and interleukin 18. J Invest Dermatol. 2003;120:990-7.         [ Links ]

41. Lebre MC, van der Aar AM, van Baarsen L, van Capel TM, Schuitemaker JH, Kapsenberg ML et al. Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9. J Invest Dermatol. 2007;127:331-41.         [ Links ]

42. Renn CN, Sanchez DJ, Ochoa MT, Legaspi AJ, Oh CK, Liu PT, et al. TLR activation of Langerhans cell-like dendritic cells triggers an antiviral immune response. J Immunol. 2006;177:298-305.         [ Links ]

43. Tada H, Nemoto E, Shimauchi H, Watanabe T, Mikami T, Matsumoto T et al. Saccharomyces cerevisiae- and Candida albicans-derived mannan induced production of tumor necrosis factor alpha by human monocytes in a CD14- and Toll-like receptor 4-dependent manner. Microbiol Immunol. 2002;46:503-12.         [ Links ]

44. Jouault T, Ibata-Ombetta S, Takeuchi O, Trinel PA, Sacchetti P, Lefebvre P et al. Candida albicans phospholipomannan is sensed through toll-like receptors. J Infect Dis. 2003;188:165-72.         [ Links ]

45. Pivarcsi A, Bodai L, Réthi B, Kenderessy-Szabó A, Koreck A, Széll M Et Al. Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int Immunol. 2003;15:721-30.         [ Links ]

46. Diniz SN, Normizo R, Cisalpino OS, Teixeira MM, Brown GD, Mantovani A, et al. PTX3 function as an opsonin for the dectin-1-dependent internalization of zymosan by machophages. J Leukoc Biol. 2004;75:649-56.         [ Links ]

47. Biondo C, Midiri A, Messina L, Tomasello F, Garufi G, Catania MR, et al. MyD88 and TLR2, but not TLR4, are required for host defense against Cryptococcus neoformans. Eur J Immunol. 2005;35:870-8.         [ Links ]

48. Wu C, Li C, Wei L, Zheng. Innate immune modulation of keratinocyte by antikeratin 16 antibodies. Exp Dermatol. 2008,17:645-52.         [ Links ]

49. Zhao J, Wu X. Aspergillus fumigatus Antigens Activate Immortalized Human Corneal Epithelial Cell via Toll-like Receptors 2 and 4. Curr Eye Res. 2008;33:447-54.         [ Links ]

50. Ferreira KS, Bastos KR, Russo M, Almeida SR. Interaction between Paracoccidioides brasiliensis and Pulmonary Dendritic Cells Induces Interleukin-10 Production and Toll-Like Receptor-2 Expression: Possible Mechanisms of Susceptibility. J Infect Dis. 2007;196:1108-15.         [ Links ]

 

 

Mailing address:
Cidia Vasconcellos
R. Capitdo Domingos, 77 - Abadia
38025-010 Uberaba - MG, Brazil
Phones.: (34) 3315-4800; (34) 3332-0534 (res.); (34) 9976-2362 (cel.); (34) 3326-1606 (alt.)
E-mail: cidiav@usp.br

 

Received on 14.07.2010
Approved by the Editorial Board and accepted for publication on 08.10.2010.
Conflict of interest: None
Financial funding: O presente trabalho foi desenvolvido com bolsas de iniciação cientifica vinculadas ao programa de pós-graduação em ciências da saúde do Iamspe, das alunas Filomena Amaro Takiguti (CNPQ n. 122819/2008) e Luciana Vasconcellos Benini (CNPQ n. 129074/2009), sob a orientação da Prof.

 

 

* Work conducted at the Department of Dermatology, Faculty of Medicine, University of São Paulo; Medical Mycology Laboratory of the Tropical Medicine Institute of São Paulo, USP IAMSPE, UNICID and Oswaldo Cruz Faculties Foundation - São Paulo (SP), Brazil.